Tributary Capital Management, LLC Abbott Laboratories Transaction History

Tributary Capital Management, LLC

$1.29 Billion
Q3 2024

A detailed history of Tributary Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tributary Capital Management, LLC holds 6,822 shares of ABT stock, worth $773,887. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,822

Previous 7,093 3.82%

Holding current value

$773,887

Previous $737,000 5.43%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $27,118 - $32,013	-271 Reduced 3.82%	6,822 $777,000
Q2 2024 Jul 24, 2024	SELL	$100.73 - $112.44 $29,816 - $33,282	-296 Reduced 4.01%	7,093 $737,000
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $21,904 - $24,192	-200 Reduced 2.64%	7,389 $839,000
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $2,705 - $3,312	-30 Reduced 0.39%	7,589 $835,000
Q3 2023 Oct 11, 2023	SELL	$95.53 - $114.62 $9,553 - $11,462	-100 Reduced 1.3%	7,619 $737,000
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $12,698 - $14,148	126 Added 1.66%	7,719 $841,000
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $13,076 - $15,391	-135 Reduced 1.75%	7,593 $768,000
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $10,456 - $12,267	-110 Reduced 1.4%	7,728 $848,000
Q3 2022 Oct 11, 2022	SELL	$96.76 - $112.03 $9,676 - $11,203	-100 Reduced 1.26%	7,838 $758,000
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $89,311 - $107,948	875 Added 12.39%	7,938 $862,000
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $22,804 - $27,808	-200 Reduced 2.75%	7,063 $836,000
Q4 2021 Jan 06, 2022	SELL	$115.53 - $141.46 $34,659 - $42,438	-300 Reduced 3.97%	7,263 $1.02 Million
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $151,658 - $167,778	1,300 Added 20.76%	7,563 $893,000
Q2 2021 Jul 15, 2021	BUY	$105.79 - $124.53 $206,078 - $242,584	1,948 Added 45.14%	6,263 $726,000
Q1 2021 Apr 20, 2021	BUY	$108.84 - $128.23 $469,644 - $553,312	4,315 New	4,315 $517,000
Q1 2019 Apr 17, 2019	SELL	$66.22 - $80.06 $128,466 - $155,316	-1,940 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$65.56 - $74.27 $127,186 - $144,083	1,940 New	1,940 $140,000
Q3 2018 Oct 16, 2018	SELL	$60.81 - $73.36 $97,296 - $117,376	-1,600 Closed	0 $0
Q2 2018 Oct 17, 2018	SELL	$57.57 - $63.54 $2.88 Million - $3.17 Million	-49,960 Reduced 96.9%	1,600 $98,000
Q2 2018 Jul 25, 2018	BUY	$57.57 - $63.54 $2.85 Million - $3.15 Million	49,580 Added 2504.04%	51,560 $3.15 Million
Q1 2018 Apr 19, 2018	BUY	$56.27 - $63.62 $111,414 - $125,967	1,980 New	1,980 $119,000
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $106,286 - $113,790	-1,980 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $95,158 - $106,207	1,980	1,980 $106,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.

Account

Tributary Capital Management, LLC Abbott Laboratories Transaction History